Compare FCCO & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCCO | SGHT |
|---|---|---|
| Founded | 1994 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.5M | 309.6M |
| IPO Year | 2012 | 2021 |
| Metric | FCCO | SGHT |
|---|---|---|
| Price | $33.76 | $8.05 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.08 |
| AVG Volume (30 Days) | 39.2K | ★ 138.2K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | ★ 36.46 | 28.16 |
| EPS | ★ 1.39 | N/A |
| Revenue | $922,000.00 | ★ $77,363,000.00 |
| Revenue This Year | $30.67 | $11.67 |
| Revenue Next Year | $5.87 | $10.39 |
| P/E Ratio | $24.32 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.92 | $3.19 |
| 52 Week High | $35.74 | $9.24 |
| Indicator | FCCO | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 55.00 | 58.89 |
| Support Level | $32.44 | $8.00 |
| Resistance Level | $35.45 | $8.80 |
| Average True Range (ATR) | 0.79 | 0.36 |
| MACD | 0.03 | -0.13 |
| Stochastic Oscillator | 69.66 | 40.37 |
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.